Article
Development of Oxytolerant Salmonella typhimurium Using Radiation Mutation Technology (RMT) for Cancer Therapy.
Scientific reports - 28 Feb 2020
Gao Shuang, Jung Jong-Hyun, Lin Shun-Mei, Jang A-Yeung, Zhi Yong, Bum Ahn Ki, Ji Hyun-Jung, Hyang Lim Jae, Guo Huichen, Choy Hyon E, Lim Sangyong, Seo Ho Seong
Abstract excerpt
A critical limitation of Salmonella typhimurium (S. typhimurium) as an anti-cancer agent is the loss of their invasive or replicative activities, which results in no or less delivery of anti-cancer agents inside cancer cells in cancer therapy. Here we developed an oxytolerant attenuated Salmonella strain (KST0650) from the parental KST0649 (ΔptsIΔcrr) strain using radiation mutation technology (RMT). The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
